Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study

BACKGROUND: Reports have suggested that the efficacy of vaccines against COVID-19 might have fallen since the delta (B.1.617.2) SARS-CoV-2 variant replaced the alpha (B.1.1.7) variant as the predominant variant. We aimed to investigate, for the two main classes of vaccine, whether efficacy against s...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeigue, Paul M, McAllister, David A, Hutchinson, Sharon J, Robertson, Chris, Stockton, Diane, Colhoun, Helen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880999/
https://www.ncbi.nlm.nih.gov/pubmed/35227416
http://dx.doi.org/10.1016/S2213-2600(22)00045-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880999/
https://www.ncbi.nlm.nih.gov/pubmed/35227416
http://dx.doi.org/10.1016/S2213-2600(22)00045-5

Ejemplares similares